The observations described above, together with our reported yeast model and the pathobiology of the SCAN1 related TDP1 mutant, support the proposed novel treatment strategy of molecular targeting stabilization of the TDP1-DNA covalent complex for cancer treatment. Here, TDP1 is linked to cancer.